Detalhe da pesquisa
1.
Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin.
Antimicrob Agents Chemother
; 68(5): e0170123, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534101
2.
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown.
Eur Respir J
; 58(3)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926970
3.
Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations.
J Clin Microbiol
; 51(8): 2641-5, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23761146
4.
Rifampin drug resistance tests for tuberculosis: challenging the gold standard.
J Clin Microbiol
; 51(8): 2633-40, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23761144
5.
Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda.
Int J Mycobacteriol
; 12(3): 274-281, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37721232
6.
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.
Lancet Microbe
; 1(2): e74-e83, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544156
7.
Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
PLoS One
; 12(10): e0187211, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29088294
8.
Multicenter external quality assessment program for PCR detection of Mycobacterium ulcerans in clinical and environmental specimens.
PLoS One
; 9(2): e89407, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24586755